Editas Medicine Stock Forecast

Buy candidate since Jun 26, 2026 Gain 15.09%

The Editas Medicine, Inc stock price gained 1.23% on the last trading day (Wednesday, 1st Jul 2026), rising from $3.24 to $3.28. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 11.34% from a day low at $3.13 to a day high of $3.49. The price has risen in 8 of the last 10 days and is up by 38.98% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $9.78 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $3.44 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -8.76% during the next 3 months and, with a 90% probability hold a price between $2.10 and $3.14 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

EDIT Signals & Forecast

Mostly positive signals in the chart today. The Editas Medicine, Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.98 and $2.83. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 38.98%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Editas Medicine, Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.08 and $2.85. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Editas Medicine, Inc finds support just below today's level at $3.08. If this is broken, then the next support from accumulated volume will be at $2.85 and $2.80.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.355 between high and low, or 11.34%. For the last week, the stock has had daily average volatility of 9.49%.

The Editas Medicine, Inc stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $3.17 (-3.42%) (This stock has high daily movements and this gives high risk. The RSI14 is 79 and this increases the risk substantially. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (EDIT) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Editas Medicine, Inc to open at $3.30, and during the day (based on 14 day Average True Range), to move between $3.15 and $3.41, which gives a possible trading interval of +/-$0.257 (+/-8.15%) up or down from last closing price. If Editas Medicine, Inc takes out the full calculated possible swing range there will be an estimated 8.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.43 (4.57%) than the support at $3.08 (6.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Editas Medicine, Inc stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 1.541 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 2, 2026 - $3.30 ( 0.559%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk